1-Dodecylimidazole
CAS No. 4303-67-7
1-Dodecylimidazole ( N-Dodecylimidazole )
产品货号. M28150 CAS No. 4303-67-7
1-十二烷基咪唑 (N-十二烷基咪唑) 是一种溶酶体去污剂和细胞毒剂。 1-十二烷基咪唑通过其在溶酶体中的酸依赖性积累、溶酶体膜的破坏以及半胱氨酸蛋白酶释放到细胞质中而导致细胞死亡。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
200MG | ¥446 | 有现货 |
|
500MG | ¥599 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称1-Dodecylimidazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述1-十二烷基咪唑 (N-十二烷基咪唑) 是一种溶酶体去污剂和细胞毒剂。 1-十二烷基咪唑通过其在溶酶体中的酸依赖性积累、溶酶体膜的破坏以及半胱氨酸蛋白酶释放到细胞质中而导致细胞死亡。
-
产品描述1-Dodecylimidazole (N-Dodecylimidazole) is a lysosomotropic detergent and a cytotoxic agent. 1-Dodecylimidazole causes cell death by its acid-dependent accumulation in lysosomes, disruption of the lysosomal membrane, and releaseof cysteine proteases into the cytoplasm. 1-Dodecylimidazole has hypocholesterolaemic activity and broad-spectrum antifungal activity.(In Vitro):N-dodecylimidazole, an acid activated detergent with a pKa of 6.3, has been shown to be cytotoxic to cells in culture. N-dodecylimidazole displayed extracellular pH (pHe)-dependent cytotoxicity against EMT-6 and MGH U1 cells. cell killing was dose dependent and was 100-fold greater at pHe 6.0 than pHe 7.0.(In Vivo):The hypocholesterolaemic activity of 1-dodecylimidazole results in part from the inhibition of cholesterol biosynthesis at the level of 2,3-oxidosqualene sterol cyclase.1-dodecylimidazole (150 mg/kg body wt; by stomach tube; daily for 10 days) has lower serum cholesterol concentrations than control rats.
-
体外实验——
-
体内实验Animal Model:Male ratsDosage:150 mg/kg body wt Administration:By stomach tube; daily for 10 days Result:Had significantly lower serum cholesterol concentrations than untreated animals.
-
同义词N-Dodecylimidazole
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Drug Metabolite
-
研究领域——
-
适应症——
化学信息
-
CAS Number4303-67-7
-
分子量236.403
-
分子式C15H28N2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (423.01 mM)
-
SMILESCCCCCCCCCCCCn1ccnc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Arnel Stockis, et al. Identification of mebeverine acid as the main circulating metabolite of mebeverine in man. J Pharm Biomed Anal. 2002 Jun 20;29(1-2):335-40.